Garutadustat

N/A

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NameGarutadustat
Drug Alias NameISM5411ISM-5411ISM012-042
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProlyl hydroxylase domain-containing protein 1 inhibitorsProlyl hydroxylase domain-containing protein 2 inhibitors
TargetsProlyl hydroxylase domain-containing protein 1Prolyl hydroxylase domain-containing protein 2
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesInsilico Medicine Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInsilico Medicine LtdInSilico Medicine Hong Kong Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A